Diamines & Chemicals Ltd
Incorporated in 1976, Diamines and Chemicals Ltd is in the business of manufacturing and marketing of organic chemicals compounds[1]
- Market Cap ₹ 249 Cr.
- Current Price ₹ 248
- High / Low ₹ 458 / 208
- Stock P/E
- Book Value ₹ 157
- Dividend Yield 0.40 %
- ROCE -8.35 %
- ROE -8.02 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Promoter holding has increased by 2.06% over last quarter.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -9.34% over past five years.
- Company has a low return on equity of 1.18% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 67 | 57 | 44 | 39 | 36 | 63 | 66 | 110 | 104 | 71 | 38 | |
| 57 | 50 | 38 | 34 | 31 | 37 | 44 | 55 | 81 | 66 | 52 | |
| Operating Profit | 10 | 8 | 6 | 5 | 4 | 26 | 22 | 56 | 23 | 5 | -14 |
| OPM % | 15% | 14% | 13% | 13% | 13% | 41% | 33% | 50% | 22% | 8% | -36% |
| 0 | 0 | 0 | 0 | 0 | 2 | 2 | 3 | 3 | 3 | 4 | |
| Interest | 4 | 4 | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 4 |
| Profit before tax | 5 | 2 | 0 | -0 | 0 | 26 | 22 | 56 | 22 | 5 | -14 |
| Tax % | 29% | 25% | 9% | 379% | -212% | 19% | 24% | 26% | 28% | 38% | -10% |
| 4 | 1 | 0 | -2 | 0 | 21 | 17 | 42 | 15 | 3 | -13 | |
| EPS in Rs | 3.60 | 1.38 | 0.40 | -1.63 | 0.26 | 21.46 | 17.08 | 42.83 | 15.81 | 2.79 | -12.71 |
| Dividend Payout % | 28% | 4% | 0% | 0% | 0% | 23% | 18% | 7% | 16% | 36% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -9% |
| 3 Years: | -30% |
| TTM: | -46% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -565% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | -3% |
| 3 Years: | -26% |
| 1 Year: | -32% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 1% |
| Last Year: | -8% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 24 | 24 | 25 | 23 | 23 | 75 | 90 | 125 | 138 | 151 | 147 |
| 26 | 20 | 20 | 20 | 16 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 15 | 13 | 10 | 10 | 9 | 10 | 10 | 17 | 15 | 17 | 9 | |
| Total Liabilities | 75 | 66 | 65 | 63 | 57 | 95 | 111 | 151 | 163 | 178 | 174 |
| 35 | 33 | 32 | 29 | 27 | 22 | 38 | 40 | 65 | 64 | 65 | |
| CWIP | 1 | 2 | 1 | 1 | 1 | 0 | 2 | 21 | 1 | 2 | 19 |
| Investments | 0 | 0 | 0 | 0 | 0 | 6 | 13 | 13 | 16 | 16 | 10 |
| 39 | 32 | 32 | 32 | 28 | 66 | 58 | 76 | 81 | 96 | 80 | |
| Total Assets | 75 | 66 | 65 | 63 | 57 | 95 | 111 | 151 | 163 | 178 | 174 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1 | 16 | 3 | 2 | 7 | 15 | 27 | 16 | 22 | -5 | -11 | |
| -4 | -5 | 1 | 1 | 0 | -15 | -21 | -9 | -19 | 15 | -29 | |
| 5 | -11 | -4 | -3 | -7 | -4 | -5 | -6 | -3 | 10 | 18 | |
| Net Cash Flow | -0 | -0 | -0 | -0 | -0 | -3 | 0 | 2 | -0 | 19 | -22 |
| Free Cash Flow | -5 | 11 | 2 | 2 | 7 | 4 | 15 | -7 | 13 | -9 | -32 |
| CFO/OP | 16% | 212% | 50% | 54% | 161% | 85% | 152% | 56% | 125% | -75% | 72% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 56 | 66 | 67 | 73 | 76 | 55 | 55 | 76 | 59 | 71 | 52 |
| Inventory Days | 178 | 122 | 184 | 184 | 155 | 284 | 43 | 234 | 135 | 336 | 473 |
| Days Payable | 71 | 58 | 67 | 52 | 34 | 65 | 45 | 105 | 40 | 93 | 45 |
| Cash Conversion Cycle | 163 | 130 | 184 | 205 | 196 | 273 | 54 | 204 | 154 | 313 | 481 |
| Working Capital Days | -1 | -14 | 11 | 32 | 26 | 103 | 40 | 96 | 94 | 185 | 244 |
| ROCE % | 10% | 7% | 6% | 6% | 24% | 48% | 16% | 3% | -8% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Production Volume - Specialty Chemicals MT ・Standalone data |
|
|||||||||||
| Sales Volume - Specialty Chemicals MT ・Standalone data |
||||||||||||
| Electricity Consumption per Tonne of Production Units/MT ・Standalone data |
||||||||||||
| Wind Power Installed Capacity MW ・Standalone data |
||||||||||||
| R&D Expenditure (Percentage of Turnover) % ・Standalone data |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
30 May - We submit herewith copies of Notice published in Newspapers regarding transfer of shares of the Company to the Investor Education and Protection Fund.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Annual Secretarial Compliance Report for FY 2025-26 filed; no non-compliances observed.
-
Announcement Under Regulation 30 - Notice To Shareholders In Respect Of Transfer Of Shares Of The Company To The Investor Education And Protection Fund (IEPF)
29 May - Notice sent to shareholders on 29 May 2026 for transfer of unclaimed dividend shares to IEPF by 31 Aug 2026.
-
Statement Of Deviation & Variation Under Reg 32
18 May - Filed March 2026 deviation report for ₹50.58 crore warrant issue; ₹12.51 crore utilized, 2,69,402 shares allotted.
-
Disclosure under Regulation 30A of LODR
18 May - Tanmay Godiawala and Rajendra Chhabra re-appointed; cost, internal and tax auditors appointed for FY 2026-27.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
DCL is an ISO 9001:2015, ISO 9001:2015, ISO 14001:2015 & ISO 45001:2018, and DSIR-certified sole manufacturer of ethylene amines in India. It also manufactures Piperazine Anhydrous and Piperazine Solutions.